{"schema_version":"secwatch.filing_event.v1","accession":"0001477449-24-000157","form_type":"8-K","ticker":"TDOC","cik":"0001477449","company_name":"Teladoc Health, Inc.","filed_at":"2024-06-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:18.588376+00:00","generated_at":"2026-06-01T05:16:40.770896+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Teladoc Health names Chuck Divita as CEO effective June 10, 2024","bullets":["Charles Divita appointed CEO and board member; Mala Murthy returns to CFO role.","Divita previously EVP Commercial Markets at GuideWell/Florida Blue, overseeing $23B in revenue.","New-hire equity award valued at ~$15M: 939,849 PSUs and 469,924 RSUs; base salary $800,000.","Company amended 2023 Inducement Plan, increasing reserved shares by 4M to 4.5M for CEO grants.","Mala Murthy's severance agreement amended to provide two years of enhanced severance protections."],"urls":{"canonical":"https://secwatch.observer/filing/0001477449-24-000157","json":"https://secwatch.observer/filing/0001477449-24-000157.json","markdown":"https://secwatch.observer/filing/0001477449-24-000157.md","text":"https://secwatch.observer/filing/0001477449-24-000157.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/0001477449-24-000157-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/tdoc-20240605.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-01T05:16:40.770896+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5ea6310536","claim":"Charles Divita, III was appointed as Director at Teladoc Health, Inc..","evidence_excerpt":"appointed Mr. Divita as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/0001477449-24-000157-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"},{"claim_id":"88d626a716","claim":"Charles Divita, III was appointed as Chief Executive Officer at Teladoc Health, Inc..","evidence_excerpt":"Charles Divita, III joined Teladoc Health, Inc. (the “Company”) as its Chief Executive Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/0001477449-24-000157-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"joined"},{"label":"Role","value":"Chief Executive Officer"}],"fact_type":"executive_change"},{"claim_id":"b245a16475","claim":"Mala Murthy changed role as Chief Financial Officer at Teladoc Health, Inc..","evidence_excerpt":"Mala Murthy stepped down as acting Chief Executive Officer of the Company and will remain the Company's Chief Financial Officer.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1477449/000147744924000157/0001477449-24-000157-index.htm","confidence":1.0,"family_label":"Executive change","details":[{"label":"Action","value":"stepped down as acting Chief Executive Officer"},{"label":"Role","value":"Chief Financial Officer"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}